Cargando…

Tirzepatide—Friend or Foe in Diabetic Cancer Patients?

It is a well-accepted fact that obesity and diabetes increase the risk of incidence of different cancers and their progression, leading to a decrease in the quality of life among affected cancer patients. In addition to decreasing the risk of cancers, maintaining a healthy body mass index (BMI)/body...

Descripción completa

Detalles Bibliográficos
Autores principales:	Samuel, Samson Mathews, Varghese, Elizabeth, Kubatka, Peter, Büsselberg, Dietrich
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9687454/ https://www.ncbi.nlm.nih.gov/pubmed/36358930 http://dx.doi.org/10.3390/biom12111580

Ejemplares similares

Diabetes and coronavirus (SARS-CoV-2): Molecular mechanism of Metformin intervention and the scientific basis of drug repurposing
por: Varghese, Elizabeth, et al.
Publicado: (2021)

Anti-Angiogenic Effects of Phytochemicals on miRNA Regulating Breast Cancer Progression
por: Varghese, Elizabeth, et al.
Publicado: (2020)

Metformin: The Answer to Cancer in a Flower? Current Knowledge and Future Prospects of Metformin as an Anti-Cancer Agent in Breast Cancer
por: Samuel, Samson Mathews, et al.
Publicado: (2019)

Counteracting Chemoresistance with Metformin in Breast Cancers: Targeting Cancer Stem Cells
por: Samuel, Samson Mathews, et al.
Publicado: (2020)

High Glucose Represses the Anti-Proliferative and Pro-Apoptotic Effect of Metformin in Triple Negative Breast Cancer Cells
por: Varghese, Sharon, et al.
Publicado: (2019)

Flavonoids in Cancer and Apoptosis
por: Abotaleb, Mariam, et al.
Publicado: (2018)

Targeting Glucose Metabolism to Overcome Resistance to Anticancer Chemotherapy in Breast Cancer
por: Varghese, Elizabeth, et al.
Publicado: (2020)

Treating Cancers Using Nature’s Medicine: Significance and Challenges
por: Samuel, Samson Mathews, et al.
Publicado: (2021)

Anti-Cancer Agents in Proliferation and Cell Death: The Calcium Connection
por: Varghese, Elizabeth, et al.
Publicado: (2019)

The Juggernaut of Adaptive Metabolism in Cancers: Implications and Therapeutic Targets
por: Samuel, Samson Mathews, et al.
Publicado: (2022)

Resveratrol’s Anti-Cancer Effects through the Modulation of Tumor Glucose Metabolism
por: Brockmueller, Aranka, et al.
Publicado: (2021)

Therapeutic Potential of Metformin in COVID-19: Reasoning for Its Protective Role
por: Samuel, Samson Mathews, et al.
Publicado: (2021)

The “Yin and Yang” of Natural Compounds in Anticancer Therapy of Triple-Negative Breast Cancers
por: Varghese, Elizabeth, et al.
Publicado: (2018)

ZEB Proteins in Leukemia: Friends, Foes, or Friendly Foes?
por: Soen, Bieke, et al.
Publicado: (2018)

Carotenoids in Cancer Apoptosis—The Road from Bench to Bedside and Back
por: Koklesova, Lenka, et al.
Publicado: (2020)

Homocysteine metabolism as the target for predictive medical approach, disease prevention, prognosis, and treatments tailored to the person
por: Koklesova, Lenka, et al.
Publicado: (2021)

The Influence of Gut Microbial Species on Diabetes Mellitus
por: AL-Ishaq, Raghad Khalid, et al.
Publicado: (2023)

Triptolide Decreases Cell Proliferation and Induces Cell Death in Triple Negative MDA-MB-231 Breast Cancer Cells
por: Varghese, Elizabeth, et al.
Publicado: (2018)

Flavonoids in Cancer Metastasis
por: Liskova, Alena, et al.
Publicado: (2020)

COVID-19 Vaccines and Hyperglycemia—Is There a Need for Postvaccination Surveillance?
por: Samuel, Samson Mathews, et al.
Publicado: (2022)

Fibronectin in Cancer: Friend or Foe
por: Lin, Tsung-Cheng, et al.
Publicado: (2019)

Pyroptosis in Cancer: Friend or Foe?
por: Lu, Xiuxia, et al.
Publicado: (2021)

Dietary Phytochemicals Targeting Cancer Stem Cells
por: Liskova, Alena, et al.
Publicado: (2019)

Combination Therapy with Vitamin C Could Eradicate Cancer Stem Cells
por: Satheesh, Noothan Jyothi, et al.
Publicado: (2020)

Tirzepatide for type 2 diabetes
por: Anderson, Sarah L, et al.
Publicado: (2023)

Flavonoids’ Dual Benefits in Gastrointestinal Cancer and Diabetes: A Potential Treatment on the Horizon?
por: AL-Ishaq, Raghad Khalid, et al.
Publicado: (2022)

Ketone Bodies in Diabetes Mellitus: Friend or Foe?
por: Veneti, Stavroula, et al.
Publicado: (2023)

STAT3 in Cancer—Friend or Foe?
por: Zhang, Hai-Feng, et al.
Publicado: (2014)

NFKB1 and Cancer: Friend or Foe?
por: Concetti, Julia, et al.
Publicado: (2018)

Friend or Foe: S100 Proteins in Cancer
por: Allgöwer, Chantal, et al.
Publicado: (2020)

Fibroblasts in cancer dormancy: foe or friend?
por: Dai, Li, et al.
Publicado: (2021)

Microbiome—Friend or Foe of Pancreatic Cancer?
por: Daniluk, Jaroslaw, et al.
Publicado: (2021)

Lithium in Cancer Therapy: Friend or Foe?
por: Yang, Chunhao, et al.
Publicado: (2023)

Sweeteners and the Gut Microbiome: Effects on Gastrointestinal Cancers
por: AL-Ishaq, Raghad Khalid, et al.
Publicado: (2023)

T Cells in Gastric Cancer: Friends or Foes
por: Amedei, Amedeo, et al.
Publicado: (2012)

Therapeutic Potential of Plant Phenolic Acids in the Treatment of Cancer
por: Abotaleb, Mariam, et al.
Publicado: (2020)

The Plant-Derived Compound Resveratrol in Brain Cancer: A Review
por: Kiskova, Terezia, et al.
Publicado: (2020)

Iron in Porphyrias: Friend or Foe?
por: Buzzetti, Elena, et al.
Publicado: (2022)

Friend and Foe
Publicado: (1890)

HAART and the liver: friend or foe?
por: Pineda, JA, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_jkrdinorui44so6setel1biue4